Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood

doi:10.1136/bmj.320.7232.403

BMJ 2000;320:403-406 ( 12 February )

Papers

Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood

Fiona A M Regan, research fellow, Patricia Hewitt, lead consultant in transfusion microbiology, John A J Barbara, lead scientist in transfusion microbiology, Marcela Contreras, executive director,

National Blood Service, London and South East Zone, North London Centre, London NW9 5BG

Correspondence to: P Hewitt patricia.hewitt{at}nbs.nhs.uk

Objectives: To follow up recipients of 20 000 units ofblood to identify any transmissions of infections through bloodtransfusion.
Design: Follow up study of recipients oftransfusion.
Setting: 22 hospitals in northLondon.
Participant: Adult patients who had recently beentransfused.
Main outcome measures: Patients had further blood samples taken at9 months that were tested for markers of hepatitis B and C andHIV and human T cell leukaemia/lymphoma virus type I or II (HTLV)infections. Recent infections were distinguished from pre-existinginfections by comparison with blood samples taken beforetransfusion.
Results: 9220 patients were recruited, and 5579 recipientsof 21 923 units of blood were followed up. No transfusion transmittedinfections were identified. The incidence of transfusion transmittedinfections was 0 in 21 043 units (95% confidence interval forrisk 0 to 1 in 5706 recipients) for hepatitis B; 0 in 21 800 units(0 to 1 in 5911 recipients) for hepatitis C; 0 in 21 923 units(0 to 1 in 5944 recipients) for HIV; and 0 in 21 902 units (0to 1 in 5939 recipients) for human T cell leukaemia/lymphoma virus.Three patients acquired hepatitis B during or after hospital admissionbut not through transfusion; 176 (3%) had pre-existing hepatitisB infection. Sixteen (0.29%) patients had hepatitis C, and five(0.09%) had human T cell leukaemia/lymphomavirus.
Conclusions: The current risk of transfusion transmittedinfections in the United Kingdom is very small, though hospitalacquired infections may arise from sources other than transfusion.A considerable proportion of patients have pre-existinginfections.

© BMJ 2000

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Articles

Transfusion transmitted infection: Gregor Caspari, Fiona Regan, Pat Hewitt, and John Barbara
BMJ 2000 321: 704. [Extract] [Full Text]

Risk of infection from blood transfusion in UK is negligible
BMJ 2000 320: 0. [Full Text]

This article has been cited by other articles:

Pryor, S. G., Sykes, J., Tollefson, T. T. (2008). Efficacy of Fibrin Sealant (Human) (Evicel) in Rhinoplasty: A Prospective, Randomized, Single-Blind Trial of the Use of Fibrin Sealant in Lateral Osteotomy. Arch Facial Plast Surg 10: 339-344 [Abstract] [Full text]
Zoumalan, R., Rizk, S. S. (2008). Hematoma Rates in Drainless Deep-Plane Face-lift Surgery With and Without the Use of Fibrin Glue. Arch Facial Plast Surg 10: 103-107 [Abstract] [Full text]
Manzini, P., Girotto, M., Borsotti, R., Giachino, O., Guaschino, R., Lanteri, M., Testa, D., Ghiazza, P., Vacchini, M., Danielle, F., Pizzi, A., Valpreda, C., Castagno, F., Curti, F., Magistroni, P., Abate, M. L., Smedile, A., Rizzetto, M. (2007). Italian blood donors with anti-HBc and occult hepatitis B virus infection. haematol 92: 1664-1670 [Abstract] [Full text]
Ng, T, Marx, G, Littlewood, T, Macdougall, I (2003). Recombinant erythropoietin in clinical practice. Postgrad. Med. J. 79: 367-376 [Abstract] [Full text]
Caspari, G., Regan, F., Hewitt, P., Barbara, J. (2000). Transfusion transmitted infection. BMJ 321: 704a-704 [Full text]
(2000). Screened Donors Means Safe Blood Transfusions. JWatch Infect. Diseases 2000: 12-12 [Full text]

Rapid Responses:

Read all Rapid Responses

Transfusion risk underestimated.: Chris Cowie
bmj.com, 2 Mar 2000 [Full text]
Systematic underestimation of transfusion risks?: Gregor Caspari
bmj.com, 8 Mar 2000 [Full text]
SCREENING FOR HTLV-I - WHY WAIT ?: Tony Pagliuca
bmj.com, 27 Mar 2000 [Full text]